Tadashi Goto
Yokohama, 2258503, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
Journal: PloS one
Published: June 11, 2013
IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal.
Journal: Case reports in gastroenterology
Published: January 24, 2013
CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.
Journal: The American journal of gastroenterology
Published: September 25, 2012
MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.
Journal: Hepatology (Baltimore, Md.)
Published: March 30, 2012
A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function.
Journal: Biochemical and biophysical research communications
Published: February 28, 2012
Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Journal: Journal of vascular and interventional radiology : JVIR
Published: February 23, 2012
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Journal: The American journal of gastroenterology
Published: December 14, 2011
Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.
Journal: PloS one
Published: November 18, 2011
Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.
Journal: Journal of gastroenterology
Published: November 15, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026